EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome

Jenny P Garzon iD, Andrea Patete, Lindsey Aschbacher-Smith, Dima Qu'd, Geraldine Kelly-Mancuso, Carolyn R Raski iD, Allison Goetsch Weisman, Madison Hankins, Michael Sawin, Katherine Kim, Andy Drackley iD, Janice Zeid und 8 weitere

American Journal of Medical Genetics Part C: Seminars in Medical Genetics · 2024

DOI: 10.1002/ajmg.c.32095 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2024. Verfasst von Jenny P Garzon und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetics, Genomics, and Metabolism, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Neurofibromatosis 1, Phenotype, Chromosome Deletion. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, Oshea family, Lurie Children's was supported by an NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurofibromatosis type 1 (NF‐1) microdeletion syndrome accounts for 5 to 11% of individuals with NF‐1. The aim of our study was to characterize a large cohort of individuals with NF‐1 microdeletion syndrome and expand its natural history. We conducted a retrospective chart review from 1994 to 2024 of individuals with NF‐1 microdeletion syndrome followed at two large Neurofibromatosis Clinics. This cohort consists of 57 individuals with NF‐1 microdeletion syndrome (28 type‐1, 4 type‐2, 2 type‐3, 9 atypical deletions, and 14 indeterminate). We note 38/56 (67.9%) with describable facial features, 25/57 (43.8%) with plexiform neurofibromas, and 3/57 (5.2%) with malignant peripheral nerve sheath tumors within the observed period. The most reported neurodevelopmental manifestations from school‐age or older individuals included 39/49 (79.6%) with developmental delays, 35/49 (71.4%) with expressive and/or receptive speech delays, 33/41 (80.5%) with learning difficulties, and 23/42 (54.8%) with attention‐deficit/hyperactivity disorder. Full‐scale IQ testing data was available for 22 individuals (range: 50–96). Of the 21 adults in this cohort, 14/21 (66.7%) graduated from high school, and 4/21 (19.0%) had some college experience. Many individuals received academic support (i.e., special education, individual education plan). In this cohort, neurocognitive outcomes in adults varied more than typically reported in the literature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurofibromatosis 1PhenotypeChromosome DeletionHumansMaleFemaleChildAdolescentAdultChild, PreschoolRetrospective StudiesYoung AdultInfantMiddle AgedNeurofibromatosesChromosomes, Human, Pair 17Learning DisabilitiesIntellectual DisabilityCraniofacial Abnormalities

Stichwörter der Autor:innen

Neurofibromatosis type 1cognitive deficitsintellectual disabilitymicrodeletion syndrometumors

Autor:innen und Institutionen

  • Division of Genetics, Genomics, and Metabolism, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Department of Pediatrics, Feinberg School of Medicine of Northwestern University, Chicago, Illinois, USA.
  • Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Alabama College of Osteopathic Medicine, Dothan, Alabama, USA.
  • Division of Ophthalmology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.

ORCID-Profile: Jenny P Garzon, Carolyn R Raski, Andy Drackley

Förderung

  • NINDS NIH HHS
  • Oshea family
  • Lurie Children's was supported by an NIH

Zitieren

APA

Garzon, J. P., Patete, A., Aschbacher-Smith, L., Qu'd, D., Kelly-Mancuso, G., Raski, C. R., Weisman, A. G., Hankins, M., Sawin, M., Kim, K., Drackley, A., Zeid, J., Weaver, K. N., Hopkin, R. J., Saal, H. M., Charrow, J., Schorry, E., Listernick, R., Simpson, B. N., & Prada, C. E. (2024). Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.32095

Vancouver

Garzon JP, Patete A, Aschbacher-Smith L, Qu'd D, Kelly-Mancuso G, Raski CR, et al. Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2024. doi:10.1002/ajmg.c.32095

BibTeX
@article{Garzon2024,
  author = {Garzon, Jenny P and Patete, Andrea and Aschbacher-Smith, Lindsey and Qu'd, Dima and Kelly-Mancuso, Geraldine and Raski, Carolyn R and Weisman, Allison Goetsch and Hankins, Madison and Sawin, Michael and Kim, Katherine and Drackley, Andy and Zeid, Janice and Weaver, K Nicole and Hopkin, Robert J and Saal, Howard M and Charrow, Joel and Schorry, Elizabeth and Listernick, Robert and Simpson, Brittany N and Prada, Carlos E},
  title = {Expanding the phenotype of neurofibromatosis type 1 microdeletion syndrome},
  journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
  year = {2024},
  doi = {10.1002/ajmg.c.32095}
}
Kostenlos starten →